---
schema_version: "secwatch.filing_event.v1"
accession: "0001321732-25-000085"
form_type: "8-K"
ticker: "PEN"
cik: "0001321732"
company_name: "Penumbra Inc"
filed_at: "2025-04-23T23:59:59+00:00"
generated_at: "2026-05-23T07:55:45.409771+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Penumbra Q1 2025 revenue $324.1M (+16.3% YoY); net income $39.2M; raises U.S. thrombectomy guidance

## Summary
- Revenue $324.1M (+16.3% YoY); U.S. Thrombectomy $187.9M (+25.0%).
- Net income $39.2M; adjusted EBITDA $59.6M (18.4% margin).
- Operating income $40.4M (12.4% margin); gross margin improved to 66.6% from 65.0%.
- Raises U.S. Thrombectomy growth guidance to 20-21% YoY (from 19-20%); rev guidance reaffirmed $1.34-$1.36B.
- International revenue down 2.5% YoY (-0.1% constant currency).

## SEC filing metadata
- accession: 0001321732-25-000085
- form_type: 8-K
- ticker: PEN
- cik: 0001321732
- company_name: Penumbra Inc
- filed_at: 2025-04-23T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321732/000132173225000085/0001321732-25-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321732/000132173225000085/pen-20250423.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001321732-25-000085
- JSON: https://secwatch.observer/filing/0001321732-25-000085.json
- Plain text: https://secwatch.observer/filing/0001321732-25-000085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.